Dr. Mark Fasulo Jr., MD

Dr. Fasulo practices at Beaumont Heart & Vascular Center in Beaumont, Texas.

Dr. Fasulo's NPI, 1366686487, was assigned on April 21, 2009. Dr. Fasulo graduated from McGovern Medical School in 2006. Dr. Fasulo's Texas license number on file is M9273.

Dr. Fasulo's primary practice is Beaumont Heart & Vascular Center, at 755 N 11th St Ste P3970b, Beaumont, TX 77702. The practice phone is (409) 724-3996.

Dr. Fasulo's primary practice is Beaumont Heart & Vascular Center in Beaumont, Texas. Dr. Fasulo is also affiliated with CHRISTUS Southeast Texas St. Elizabeth. The medical group on file is UT Physicians. Dmand AI also links Dr. Fasulo to 4 more hospitals, 3 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fasulo practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fasulo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fasulo is board certified in interventional cardiology by the American Board of Internal Medicine. Dr. Fasulo has a license on file in Texas.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Fasulo treats.

CMS data shows 7,244 Medicare services from Dr. Fasulo across 50 procedure codes in 2024, for 1,901 Medicare patients. Medicare paid $922,469 for them.

CMS counts 1,901 Medicare patients who saw Dr. Fasulo in 2024. The largest group is 65 to 74, with 771 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fasulo's median patient age at 72, with 48% women.

In 2024, Dr. Fasulo wrote 9,076 Medicare Part D claims for 1,554 patients. 81% of them were for generic drugs. CMS names the drug for 8,804 of them, across 69 drugs with 11 or more claims each, at $1,526,301 in total drug cost. In 2023, CMS named 9,584 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Fasulo for performance year 2024, reported as part of a group. Dr. Fasulo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of pacemaker insertion or repair by Dr. Fasulo, more than 62% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Fasulo, published from 2014 to 2016. 2014 was the busiest year, with 2. Dr. Fasulo's most frequent co-authors are Kamran Ahrar, MD, Tam Thi Thanh Huynh, MD and Jean Hanna Tayar, MD.

Dmand AI links Dr. Fasulo to 1 clinical trial. Conditions studied include Obesity and Overnutrition. Open Payments lists research payments to Dr. Fasulo that name 1 trial.

CMS Open Payments shows 675 general payments to Dr. Fasulo from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Janssen Pharmaceuticals, Inc paid the most, $73,158. It also lists 4 research payments totaling $17,110 from 2021 to 2024, naming 1 clinical trial.

Dr. Fasulo graduated from McGovern Medical School in 2006. Dr. Fasulo is a member of ACC.

Dr. Fasulo is in network with 22 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.